14.09.2013 Views

Kapitel 4: Hantering av MS-relaterade symtom - Neuroportalen

Kapitel 4: Hantering av MS-relaterade symtom - Neuroportalen

Kapitel 4: Hantering av MS-relaterade symtom - Neuroportalen

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

KAPITEL 4: HANTERING AV <strong>MS</strong>-RELATERADE SYMTOM<br />

EUROPEISKA <strong>MS</strong>-SJUKSKÖTERSKEMANUALEN<br />

Schmidt RT, Lee RH, Spehlmann R. Treatment of spasticity in multiple sclerosis:<br />

Comparison of dantrolene sodium and diazepam. Trans Am Neurol Assoc<br />

1975;100:235-237.<br />

Smith C, Birnbaum G, Carter JL, Greenstein J, Lublin FD. Tizanidine treatment of<br />

spasticity caused by multiple sclerosis: Results of a double-blind, placebo-controlled<br />

trial. US Tizanidine Study Group. Neurology 1994;44(suppl 9):S34-S43.<br />

Smith PF, Darlington CL. Recent developments in drug therapy for multiple sclerosis.<br />

Mult Scler 1999;5:110-120.<br />

Ungerleider JT, Andyrsiak T, Fairbanks L, Ellison GW, Myers LW. Delta-9-THC in the<br />

treatment of spasticity associated with multiple sclerosis. Adv Alcohol Subst Abuse<br />

1987;7:39-50.<br />

United Kingdom Tizanidine Trial Group. A double-blind, placebo-controlled trial of<br />

tizanidine in the treatment of spasticity caused by multiple sclerosis. Neurology<br />

1994;44(suppl 9):S70-S78.<br />

4?32

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!